Related Experiment Video

Updated: Aug 7, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

p53 mutation and tamoxifen resistance in breast cancer

R M Elledge1, S Lock-Lim, D C Allred

  • 1Division of Medical Oncology and Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 1, 1995
PubMed

Insights

Mutant p53 protein did not cause tamoxifen resistance or estrogen-independent growth in breast cancer cells. Further research is needed to explore other p53 mutations and their role in treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Estrogen receptor-positive breast cancer often becomes resistant to endocrine therapies like tamoxifen.
  • The molecular mechanisms driving tamoxifen resistance and estrogen-independent growth remain unclear.
  • The role of p53 mutations in the development of treatment resistance is an area of active investigation.

Purpose of the Study:

  • To investigate whether a specific p53 mutation (codon 179) could induce tamoxifen resistance and estrogen-independent growth in breast cancer cells.
  • To test the hypothesis that p53 gene mutations contribute to endocrine therapy failure.

Main Methods:

  • MCF-7 breast cancer cells (estrogen receptor-positive, tamoxifen-sensitive, wild-type p53) were transfected with a mutated p53 cDNA (codon 179).
  • Polymerase chain reaction (PCR) confirmed the presence of the transfected mutant p53 cDNA.
  • Western blotting assessed p53 protein overexpression.
  • Monolayer and soft agar growth assays evaluated estrogen-independent growth and tamoxifen sensitivity in transfected clones.

Main Results:

  • Transfection with mutant p53 (codon 179) did not consistently lead to estrogen-independent growth or tamoxifen resistance in monolayer cultures.
  • In soft agar assays, four out of five mutant p53 transfectants remained sensitive to tamoxifen in a dose-dependent manner.
  • The presence of wild-type p53 alongside mutant 179 p53 did not confer tamoxifen resistance or estrogen-independent growth.

Conclusions:

  • The specific p53 mutation at codon 179, in the presence of wild-type p53, does not appear to be a direct cause of tamoxifen resistance or estrogen-independent growth in MCF-7 breast cancer cells.
  • These findings do not rule out the possibility that other p53 mutations could lead to treatment resistance.
  • Loss of the remaining wild-type p53 allele might be a necessary event for the development of tamoxifen resistance in conjunction with p53 mutations.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...